Literature DB >> 24451226

A stepwise likelihood ratio test procedure for rare variant selection in case-control studies.

Anthony Y C Kuk1, David J Nott1, Yaning Yang2.   

Abstract

There is much recent interest in finding rare genetic variants associated with various diseases. Owing to the scarcity of rare mutations, single-variant analyses often lack power. To enable pooling of information across variants, we use a random effect formulation within a retrospective modeling framework that respects the retrospective data collecting mechanism of case-control studies. More concretely, we model the control allele frequencies of the variants as random effects, and the systematic differences between the case and control frequencies as fixed effects, resulting in a mixed model. The use of Poisson approximation and gamma-distributed random effects results in a generalized negative binomial distribution for the joint distribution of the control and case frequencies. Variants are selected by conducting stepwise likelihood ratio tests. The superiority of the proposed method over two existing variant selection methods is demonstrated in a simulation study. The effects of non-gamma random effects and correlated variants are also found to be not too detrimental in the simulation study. When the proposed procedure is applied to identify rare variants associated with obesity, it identifies one additional variant not picked up by existing methods.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24451226     DOI: 10.1038/jhg.2014.1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Inference on haplotype effects in case-control studies using unphased genotype data.

Authors:  Michael P Epstein; Glen A Satten
Journal:  Am J Hum Genet       Date:  2003-11-20       Impact factor: 11.025

2.  Comparison of prospective and retrospective methods for haplotype inference in case-control studies.

Authors:  Glen A Satten; Michael P Epstein
Journal:  Genet Epidemiol       Date:  2004-11       Impact factor: 2.135

3.  Pooled association tests for rare variants in exon-resequencing studies.

Authors:  Alkes L Price; Gregory V Kryukov; Paul I W de Bakker; Shaun M Purcell; Jeff Staples; Lee-Jen Wei; Shamil R Sunyaev
Journal:  Am J Hum Genet       Date:  2010-05-13       Impact factor: 11.025

4.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

5.  A general framework for detecting disease associations with rare variants in sequencing studies.

Authors:  Dan-Yu Lin; Zheng-Zheng Tang
Journal:  Am J Hum Genet       Date:  2011-09-01       Impact factor: 11.025

6.  Analysis of overdispersed count data by mixtures of Poisson variables and Poisson processes.

Authors:  P Hougaard; M L Lee; G A Whitmore
Journal:  Biometrics       Date:  1997-12       Impact factor: 2.571

7.  A fast collapsed data method for estimating haplotype frequencies from pooled genotype data with applications to the study of rare variants.

Authors:  Anthony Y C Kuk; Xiang Li; Jinfeng Xu
Journal:  Stat Med       Date:  2012-08-01       Impact factor: 2.373

8.  Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.

Authors:  Eric J Topol; Marie-Germaine Bousser; Keith A A Fox; Mark A Creager; Jean-Pierre Despres; J Donald Easton; Christian W Hamm; Gilles Montalescot; P Gabriel Steg; Thomas A Pearson; Eric Cohen; Christophe Gaudin; Bernard Job; Judith H Murphy; Deepak L Bhatt
Journal:  Lancet       Date:  2010-08-14       Impact factor: 79.321

9.  Comprehensive approach to analyzing rare genetic variants.

Authors:  Thomas J Hoffmann; Nicholas J Marini; John S Witte
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

10.  A groupwise association test for rare mutations using a weighted sum statistic.

Authors:  Bo Eskerod Madsen; Sharon R Browning
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

View more
  2 in total

1.  Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.

Authors:  Wenjun Mou; Zhaoqi Liu; Yuan Luo; Meng Zou; Chao Ren; Chunyan Zhang; Xinyu Wen; Yong Wang; Yaping Tian
Journal:  Med Oncol       Date:  2014-08-14       Impact factor: 3.064

2.  A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Authors:  Izabela Karbassi; Glenn A Maston; Angela Love; Christina DiVincenzo; Corey D Braastad; Christopher D Elzinga; Alison R Bright; Domenic Previte; Ke Zhang; Charles M Rowland; Michele McCarthy; Jennifer L Lapierre; Felicita Dubois; Katelyn A Medeiros; Sat Dev Batish; Jeffrey Jones; Khalida Liaquat; Carol A Hoffman; Malgorzata Jaremko; Zhenyuan Wang; Weimin Sun; Arlene Buller-Burckle; Charles M Strom; Steven B Keiles; Joseph J Higgins
Journal:  Hum Mutat       Date:  2015-10-29       Impact factor: 4.878

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.